ADMA BIOLOGICS, INC. Derivative Liability, Noncurrent
ADMA BIOLOGICS, INC. (ADMA) had Derivative Liability, Noncurrent of $0 as of 2015-12-31, per its 10-K filed 2016-03-23.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:DerivativeLiabilitiesNoncurrent · last filed 2016-03-23
- 2015-12-31: Derivative Liability, Noncurrent $0.00.
- 2015-09-30: Derivative Liability, Noncurrent $0.00.
- 2015-06-30: Derivative Liability, Noncurrent $0.00.
- 2015-03-31: Derivative Liability, Noncurrent $0.00.
| Period end | Derivative Liability, Noncurrent |
|---|---|
| 2015-12-31 | $0.00 10-K · filed 2016-03-23 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-10 |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-11 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-12 |
| 2014-12-31 | $476.76K 10-K · filed 2016-03-23 |
| 2014-09-30 | $263.78K 10-Q · filed 2014-11-10 |
| 2014-06-30 | $249.17K 10-Q · filed 2014-08-11 |
| 2014-03-31 | $214.37K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $0.00 10-K · filed 2015-03-09 |
| 2013-09-30 | $168.78K 10-Q · filed 2013-11-12 |
| 2013-06-30 | $171.59K 10-Q · filed 2013-08-12 |
| 2013-03-31 | $192.62K 10-Q · filed 2013-05-14 |
| 2012-12-31 | $229.34K 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |